Navigation Links
Martek Announces Fourth Quarter and FY 2010 Financial Results
Date:12/8/2010

rch and development 9,1716,93833,55727,448Selling, general and administrative  21,55712,02571,15548,083Advertising and promotion4,22859114,3001,944Amortization of intangible assets3,4831,47910,5056,389Acquisition costs111—3,583—Restructuring charge30,741—31,348—Other operating expenses9541241,4591,080Total operating expenses70,24521,157165,90784,944Income (loss) from operations(8,092)17,23350,84663,616Interest (expense) income and other, net(263)1(3,555)428Income (loss) before income tax provision(8,355)17,23447,29164,044Income tax provision (benefit)  (2,209)6,19519,39123,454Net income (loss)

$

(6,146)$

11,039$

27,900$

40,590Basic earnings (loss) per share

$

(0.18)$

0.33$

0.84$

1.22Diluted earnings (loss) per share

$

(0.18)$

0.33$

0.83$

1.22Shares used in computing basic earnings (loss) per share33,49033,25333,40433,207Shares used in computing diluted earnings (loss) per share33,49033,42433,57533,363Unaudited Condensed Consolidated Balance Sheets DataOctober 31,October 31, 20102009Assets:Cash and cash equivalents

$63,746$

141,063Short-term investments—7,301Accounts receivable, net69,56944,304Inventories, net93,976116,179Other current assets6,6955,240Property, plant and equipment, net221,770252,279Deferred tax asset9,42924,303Long-term investments4,9554,495Goodwill, intangibles and other long-term assets, net328,02194,653Total assets

$798,161$

689,817Liabilities and stockholders' equity:Accounts payable and accrued expenses

$52,517$

31,365Notes payable and other long-term obligations6,938810Deferred tax liability58,97810,091Deferred revenue8,74511,407Stockholders' equity670,983636,144Total liabilities and stockholders' equity

$798,161$

689,817Unaudited Condensed Consolidated Cash Flow DataYear ended October 31,20102009Operating activities:Net income

$

2
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Martek to Present at Upcoming Citi Small / Mid Cap Conference
2. Martek to Present at Upcoming UBS Conference
3. Martek Announces Third Quarter FY 2010 Financial Results
4. Martek Announces Fourth Quarter and FY 2009 Financial Results
5. Martek Signs Sole-Source Supply Agreement with Fonterra
6. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
7. Martek Announces Addition to Its Board of Directors
8. Martek to Present at Two Upcoming Investor Conferences
9. Martek Announces Settlement of Patent Dispute with Capsugel France
10. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
11. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... HILL, N.C. , Dec. 22, 2014 /PRNewswire/ ... today announced that it has signed a letter ... company that has developed and patented a nanotechnology-based ... medical diagnostics products that enable rapid on-site collection ... alcohol use/abuse and health issues in an immediate, ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations dedicated ... has further expanded its global reach with the affiliation ... Australia, reports Mylinda Vick, CCIM, Chairman of the ITRA ... ACORPP (Australian Corporate Property and Projects) , is a ... to a wide range of clients in the private ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the nation’s ... Pharm.D. to the newly created position of Vice President ... Dr. Maroulis will continue to manage the entire specialty ... pharmacies as the company expands. Dr. Maroulis has been ... has served in many different capacities in the pharmacy, ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources Group ... grow at a 12 percent compound annual growth rate ... the aging population and the increasing adoption of dental ... will also spur demand for dental biomaterials ... implant and periodontal treatments. Other key findings ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
... facility to support clinical development for ... lead drug candidate and other molecules, ... radiopharmaceutical company that designs, develops and,manufactures products to detect, ... completed commissioning its in-house manufacturing,capability to meet clinical trial ...
... (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"),a leading ... in the People,s Republic of China, today announced its ... Second Quarter 2008 Highlights -- Revenue was ... quarter of 2007, and an ...
... 15 The backpack is a back-to-school,staple. In ... fashion accessory as,well. However, backpacks are a leading ... children and adolescents. As students head back to ... preventing,unnecessary backpack pain and injuries., The MCA ...
Cached Biology Technology:Cellectar, Inc. Begins GMP Production 2Yongye Biotechnology International Announces Second Quarter Results 2Yongye Biotechnology International Announces Second Quarter Results 3Yongye Biotechnology International Announces Second Quarter Results 4Yongye Biotechnology International Announces Second Quarter Results 5Yongye Biotechnology International Announces Second Quarter Results 6Yongye Biotechnology International Announces Second Quarter Results 7Yongye Biotechnology International Announces Second Quarter Results 8Yongye Biotechnology International Announces Second Quarter Results 9Yongye Biotechnology International Announces Second Quarter Results 10Yongye Biotechnology International Announces Second Quarter Results 11Minnesota Chiropractic Association Offers Backpack Safety Checklist 2
(Date:12/10/2014)... , December 9, 2014 ... ITN,s BCARD Platform   ... enterprise meeting scheduling solutions for business-to-business (B2B) events, ... world leader in mobile near-field communication (NFC), Bluetooth ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow ...
(Date:12/5/2014)...  Tute Genomics, a leader in cloud-based solutions for ... funding led by UK-based Eurovestech. Peak Ventures and a ... round. "We are at a pivotal time ... and seeks new approaches for the diagnosis, treatment and ... MBA, and CEO of Tute Genomics. "One of the ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Romeo Casabona is Director of the Interuniversity Professorship in Law ... of the Basque Country. The Professorship is largely made up ... in the fields of molecular biology, medicine and even specialists ... Humane Genome at the Universities of Deusto and the Basque ...
... , This release is available in German ... less than half accumulate in the atmosphere where it contributes ... and terrestrial ecosystems such as forests, grasslands and peat-lands. Stimulating ... one of the main, immediately available ways of reducing climate ...
... deletion can increase the likelihood of immune complications following ... in the November 22 advance online issue of ... missing from the donor,s genome but present in the ... serious side-effect known as graft-versus-host disease, in which immune ...
Cached Biology News:Research and legislation should go hand in hand, as much as possible 2Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4
Kinase Buffer can be used to assay protein kinase activity...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: